Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced ...

Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...

As the tariff situation continues to unfold in unexpected ways, the pharma industry must prepare for multiple eventualities.

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve ...

Arda Ural discusses the different ways that companies may change the ways they allocate resources in the current geopolitical climate.